Related Experiment Video

Updated: Jun 29, 2026

Production of Replication-Defective Retrovirus by Transient Transfection of 293T cells
09:40

Production of Replication-Defective Retrovirus by Transient Transfection of 293T cells

Published on: December 4, 2007

Retrovirus-induced oncogenesis and safety of retroviral vectors

Venugopal Nair1

  • 1Institute for Animal Health, Division of Microbiology, Oncogenic Virus Group, Compton, Berkshire, UK. venu.gopal@bbsrc.ac.uk

Current Opinion in Molecular Therapeutics
|October 3, 2008
PubMed

Insights

Gene therapy uses retroviral vectors to correct genetic defects but can cause cancer. Understanding retroviral integration is key to designing safer gene therapy vectors.

Area of Science:

  • Molecular Biology
  • Genetics
  • Oncology

Background:

  • Gene therapy holds promise for genetic diseases, with retroviral vectors being highly effective.
  • However, retroviral gene therapy has led to T-cell lymphoproliferative disease in some patients.
  • This highlights the need to understand retroviral mechanisms in host cells.

Purpose of the Study:

  • To review the molecular mechanisms of retroviral oncogenesis.
  • To explore strategies for designing safer retroviral vectors for gene therapy.

Main Methods:

  • Literature review of studies on retroviral integration and oncogenesis.
  • Analysis of molecular effects of retroviral vectors on host genomes.

Main Results:

  • Retroviral vector integration sites are critical determinants of oncogenicity.
  • Activation of non-coding sequences (e.g., microRNAs) and protein-coding genes can contribute to cancer.
  • Different retroviruses exhibit distinct integration site preferences.

Conclusions:

  • Safer retroviral vector design requires careful consideration of integration site preferences.
  • Assessing insertional effects on both coding and non-coding genomic elements is crucial for risk evaluation in gene therapy.

More Related Videos

Handling of the Cotton Rat in Studies for the Pre-clinical Evaluation of Oncolytic Viruses06:13

Handling of the Cotton Rat in Studies for the Pre-clinical Evaluation of Oncolytic Viruses

Published on: November 24, 2014

Transduction of Human Cells with Polymer-complexed Ecotropic Lentivirus for Enhanced Biosafety14:03

Transduction of Human Cells with Polymer-complexed Ecotropic Lentivirus for Enhanced Biosafety

Published on: July 24, 2011

Related Concept Videos

Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Retroviruses02:33

Retroviruses

Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...